Looking Beyond VEGF Suppression: Optimizing the Patient Journey

Theme:
Co-Developed Symposium
When:
6:30 AM, Saturday 17 Jun 2023
(1 hour 30 minutes)
Where:
Québec City Convention Centre
- Room 205 ABC | Salle 205 ABC
How:
*Breakfast to be served from 6:00am*
Learning Objectives:
At the end of this session, participants will be able to:
- Outline the role of the Tie-2/ang pathway in DR and nAMD
and how it may impact patient outcomes - Identify the most important biomarkers
on structural OCT that can help predict treatment
response in DME and nAMD - Discuss real-world case presentations and when
to switch patients from one agent to another - Highlight reasons for the efficacy gap between clinical trials and real-world practice, and describe how to address that gap with improved real-world study design (eg, VOYAGER)
CanMEDS Roles: Medical expert, scholar
Sub Sessions
- Welcome and Introductions
- Speaker Dr. Wai-Ching Lam
- 10 minutes | 6:30 AM - 6:40 AM Part of: Looking Beyond VEGF Suppression: Optimizing the Patient Journey
- Emerging treatments for neovascular AMD
- Speaker Sunir J. Garg, MD, FACS, FASRS
- 10 minutes | 6:40 AM - 6:50 AM Part of: Looking Beyond VEGF Suppression: Optimizing the Patient Journey
- Talk | Exposé
- Biomarkers to help predict treatment response in DME and nAMD
- Speaker Dr. SriniVas Sadda
- 10 minutes | 6:50 AM - 7:00 AM Part of: Looking Beyond VEGF Suppression: Optimizing the Patient Journey
- Talk | Exposé
- Update on faricimab in diabetic macular edema and neovascular AMD
- Speaker Diana V. Do, MD
- 10 minutes | 7:00 AM - 7:10 AM Part of: Looking Beyond VEGF Suppression: Optimizing the Patient Journey
- Talk | Exposé
- Case Presentations
- Presenter Dr. Shaheer Aboobaker | Presenter Dr. Wai-Ching Lam
- 20 minutes | 7:10 AM - 7:30 AM Part of: Looking Beyond VEGF Suppression: Optimizing the Patient Journey
- Case Presentation | Présentation de cas
- Q&A/ Panel Discussion
- 30 minutes | 7:30 AM - 8:00 AM Part of: Looking Beyond VEGF Suppression: Optimizing the Patient Journey
- Discussion